| | | | | | |

New Evidence of Mesothelioma Risk from Inhaled Multiwalled Carbon Nanotubes

Multi-walled_Carbon_NanotubeScientists have long suspected that inhaling multi-walled carbon nanotubes could cause malignant mesothelioma, but a new Japanese study appears to prove that it does – at least in rats.

Asbestos, a naturally-occurring mineral once widely used as an insulator and building product additive, remains the number one cause of both pleural and peritoneal mesothelioma worldwide.

But researchers have theorized that the same things that make asbestos fibers so carcinogenic – their size, shape, and chemical makeup – might make other similarly-shaped molecules like carbon nanotubes dangerous, too.

Multi-walled Carbon Nanotubes

Multi-walled carbon nanotubes (MWCNTs) are man-made cylindrical molecules of carbon arranged in a concentric pattern. Because of their extraordinary strength and thermal conductivity, MWCNTs are used in electronics and optics, as well as to strengthen carbon fibers baseball bats, golf clubs and car parts.

Like asbestos fibers, MWCNTs are long and thin which, some theorize, could cause them to become stuck in lung tissue in the same way that asbestos fibers become stuck. Over time, the body’s reaction to these biopersistent fibers could trigger cellular changes that lead to mesothelioma.

The Link Between Mesothelioma and MWCNTs

Researchers already knew that MWCNTs could be dangerous. Previous experiments have shown that rats injected with MWCNTs can develop mesothelioma.

But the question for a team of scientists from several Japanese Universities was whether or not MWCNTs could do the same thing if they were just inhaled, the way a worker might accidentally inhale them on the job. Unfortunately, the answer appears to be yes.

When a solution containing MWCNTs was sprayed through the tracheas directly into the lungs of 38 rats, six of them developed mesothelioma and 14 developed lung cancer. The results led molecular toxicologist Masumi Suzui to conclude, “Administration of MWCNT to the lung in the rat induces malignant mesothelioma and lung tumors.”

Protecting Workers from Malignant Mesothelioma

Because there is so little data on the safety of carbon nanotubes in humans, companies that use them  and government agencies have primarily based their safety recommendations on the results of animal studies like the current one.

Several international agencies, including the British Health and Safety Executive and the US National Institute of Occupational Safety and Health have published strategies for controlling workplace exposures to carbon nanotubes and implementing medical surveillance programs.

Until the hazards posed by these molecules are better understood, those who work around these materials should learn from the experience of asbestos workers and exercise caution to minimize the risk of malignant mesothelioma or other health problems.

Sources:

Suzui, M, et al, “Multiwalled carbon nanotubes intratracheally instilled in the rat lung induce development of pleural malignant mesothelioma and lung tumors:, April 21, 2016, Cancer Science, Epub ahead of print

“Current Intelligence Bulletin 65: Occupational Exposure to Carbon Nanotubes and Nanofibers”, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention website

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…